NCT04085263View on ClinicalTrials.gov

Rhomboid Intercostal and Subserratus Plane Block

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

September 6, 2022

Study Completion Date

September 6, 2022

Conditions
Postoperative PainRegional Anesthesia Morbidity
Interventions
PROCEDURE

Control group

The patients in this group will receive sham rhomboid intercostal and subserratus plane.

PROCEDURE

Rhomboid intercostal and subserratus plane block group

The patients in this group will be receive real ultrasound-guided rhomboid intercostal and subserratus plane.

Trial Locations (1)

31511

Tanta University hospitals, Tanta

All Listed Sponsors
collaborator

Dr. Mohamed shebl Abdelghany

UNKNOWN

lead

Tanta University

OTHER

NCT04085263 - Rhomboid Intercostal and Subserratus Plane Block | Biotech Hunter | Biotech Hunter